Suppr超能文献

CBP的单等位基因缺失通过ESET表达和组蛋白H3(K9)甲基化导致着丝粒周围异染色质凝聚。

Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation.

作者信息

Lee Junghee, Hagerty Sean, Cormier Kerry A, Kim Jinho, Kung Andrew L, Ferrante Robert J, Ryu Hoon

机构信息

Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA.

出版信息

Hum Mol Genet. 2008 Jun 15;17(12):1774-82. doi: 10.1093/hmg/ddn067. Epub 2008 Mar 4.

Abstract

Chromatin remodeling is tightly controlled under physiological conditions. Alterations in chromatin structure are involved in the pathogenesis of neuronal systems. We found that the monoallelic deletion of CREB binding protein (CBP) results in the induction of ERG-associated protein with SET domain (ESET) and increases trimethylation of histone H3 (K9) and condensation of pericentromeric heterochromatin structure in neurons. Nested deletion and mutational analysis of the ESET promoter further demonstrated that the Ets-2 transcription factor regulates transcriptional activity of the ESET gene. In CBP+/- mice, Ets-2 occupancy in the ESET promoter DNA was markedly elevated. Our results suggest that CBP is a transcriptional repressor of ESET gene expression by limiting Ets-2 transcriptional activity, while CBP siRNA enhances basal and Ets-2-dependent ESET transcriptional activity. Altered expression of the ESET gene and hypertrimethylation of H3 (K9) correlate with striatal neuron atrophy and dysfunction in CBP+/- mice. These results establish an alternative pathway that loss of CBP leads to the pericentric heterochromatin condensation through ESET expression and trimethylation of H3 (K9).

摘要

染色质重塑在生理条件下受到严格控制。染色质结构的改变与神经系统的发病机制有关。我们发现,CREB结合蛋白(CBP)的单等位基因缺失导致含SET结构域的ERG相关蛋白(ESET)的诱导,并增加神经元中组蛋白H3(K9)的三甲基化和着丝粒周围异染色质结构的凝聚。ESET启动子的嵌套缺失和突变分析进一步表明,Ets-2转录因子调节ESET基因的转录活性。在CBP+/-小鼠中,ESET启动子DNA中Ets-2的占有率显著升高。我们的结果表明,CBP通过限制Ets-2的转录活性是ESET基因表达的转录抑制因子,而CBP siRNA增强基础和Ets-2依赖性ESET转录活性。ESET基因表达的改变和H3(K9)的高甲基化与CBP+/-小鼠纹状体神经元萎缩和功能障碍相关。这些结果建立了一条替代途径,即CBP的缺失通过ESET表达和H3(K9)的三甲基化导致着丝粒周围异染色质凝聚。

相似文献

2
ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19176-81. doi: 10.1073/pnas.0606373103. Epub 2006 Dec 1.
3
Histone H3-K9 methyltransferase ESET is essential for early development.
Mol Cell Biol. 2004 Mar;24(6):2478-86. doi: 10.1128/MCB.24.6.2478-2486.2004.
5
A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin.
Genes Dev. 2004 Jun 1;18(11):1251-62. doi: 10.1101/gad.300704. Epub 2004 May 14.
8
In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level.
J Comput Aided Mol Des. 2017 Oct;31(10):877-889. doi: 10.1007/s10822-017-0052-3. Epub 2017 Sep 6.
9

引用本文的文献

1
Neuroinflammation and the role of epigenetic-based therapies for Huntington's disease management: the new paradigm.
Inflammopharmacology. 2024 Jun;32(3):1791-1804. doi: 10.1007/s10787-024-01477-0. Epub 2024 Apr 23.
4
Histone Methylation Regulation in Neurodegenerative Disorders.
Int J Mol Sci. 2021 Apr 28;22(9):4654. doi: 10.3390/ijms22094654.
5
KMT2C/D COMPASS complex-associated diseases [KCOM-ADs]: an emerging class of congenital regulopathies.
Clin Epigenetics. 2020 Jan 10;12(1):10. doi: 10.1186/s13148-019-0802-2.
6
In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level.
J Comput Aided Mol Des. 2017 Oct;31(10):877-889. doi: 10.1007/s10822-017-0052-3. Epub 2017 Sep 6.
7
Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases.
Int J Mol Sci. 2015 Dec 25;17(1):26. doi: 10.3390/ijms17010026.
8
The epigenetics of aging and neurodegeneration.
Prog Neurobiol. 2015 Aug;131:21-64. doi: 10.1016/j.pneurobio.2015.05.002. Epub 2015 Jun 11.
9
AGO2 and SETDB1 cooperate in promoter-targeted transcriptional silencing of the androgen receptor gene.
Nucleic Acids Res. 2014 Dec 16;42(22):13545-56. doi: 10.1093/nar/gku788. Epub 2014 Sep 2.
10
Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective.
Mol Neurobiol. 2015 Feb;51(1):406-23. doi: 10.1007/s12035-014-8715-8. Epub 2014 May 1.

本文引用的文献

1
Modulation of nucleosome dynamics in Huntington's disease.
Hum Mol Genet. 2007 May 15;16(10):1164-75. doi: 10.1093/hmg/ddm064. Epub 2007 Apr 2.
2
CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease.
Science. 2007 Mar 30;315(5820):1857-9. doi: 10.1126/science.1139517. Epub 2007 Mar 1.
3
Heterochromatin revisited.
Nat Rev Genet. 2007 Jan;8(1):35-46. doi: 10.1038/nrg2008.
4
ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19176-81. doi: 10.1073/pnas.0606373103. Epub 2006 Dec 1.
5
Uncoupling global and fine-tuning replication timing determinants for mouse pericentric heterochromatin.
J Cell Biol. 2006 Jul 17;174(2):185-94. doi: 10.1083/jcb.200601113. Epub 2006 Jul 10.
6
Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons.
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13915-20. doi: 10.1073/pnas.0502878102. Epub 2005 Sep 16.
7
Differential subnuclear localization and replication timing of histone H3 lysine 9 methylation states.
Mol Biol Cell. 2005 Jun;16(6):2872-81. doi: 10.1091/mbc.e04-11-0997. Epub 2005 Mar 23.
8
ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.
J Neurosci. 2005 Mar 2;25(9):2295-303. doi: 10.1523/JNEUROSCI.5107-04.2005.
10
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease.
J Biol Chem. 2005 Jan 7;280(1):556-63. doi: 10.1074/jbc.M410210200. Epub 2004 Oct 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验